Archives

by in
Entry Author Date Location
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
Cancer Agency Leaders in Houston, $111M in Grants Awarded 02/27/15 Texas
With FDA Nod, Nonprofit Drug Firm Launches New IUD—And New Model 02/27/15 San Francisco
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Paul Maritz Brings Cloud Expertise to Nanobiosym With Investment 02/26/15 Boston
West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More 02/26/15 San Francisco
UW Medicine Taps Telemedicine Provider Carena for New Virtual Clinic 02/26/15 Seattle
SF Startups From App-Searching Tool to Mobile Defense Get VC Funding 02/26/15 San Francisco
New Harvard i-lab Head Talks Global Expansion, Startup Initiatives 02/26/15 Boston
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
Exact Sciences’ Stock Stumbles on Early Cologuard Launch Data 02/25/15 Wisconsin
Shire Acquires Meritage Pharma in Deal Potentially Worth $245M 02/24/15 San Diego
Wisconsin Roundup: Exact Sciences, Arrowhead, MCW, Marquette, & More 02/24/15 Wisconsin
See “New York’s Life Science Disruptors” on March 12: Here’s the Agenda 02/24/15 New York
Raleigh-Durham Roundup: LabCorp, Alevo, Piedmont Pharma, & More 02/24/15 Raleigh Durham
Flexus Speeds From Inception to $1.25B Bristol Buyout In Less Than Two Years 02/23/15 San Francisco
Well-Funded NGM Bio Nabs $200M To Boost Merck’s Metabolic Pipeline 02/23/15 San Francisco
Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug 02/23/15 San Diego
Valeant to Acquire Specialty Pharma Salix in $14.5B Deal 02/22/15 Raleigh Durham
Seattle Roundup: CoCo, Glencoe, StratoScientific, APImetrics, & More 02/20/15 Seattle
Innovation Hub: Meet the Science Evangelist 02/20/15 National
WHO Approves 15-Minute Ebola Test Developed by Corgenix 02/20/15 Boulder/Denver
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Seragon CEO Rich Heyman Is Going on Hiatus 02/20/15 San Diego
As New Sanofi CEO Starts, Viehbacher’s Biotech Fingerprints Abound 02/19/15 Boston
San Antonio’s Evestra Takes $5M Loan for Gynecological Treatments 02/19/15 Texas
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Fears Percolate as Billion-Dollar Private Company Valuations Climb 02/19/15 National
Page 4 of 262 « previous page · next page »